ADAMTS15 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 15) is a secreted protease involved in extracellular matrix remodeling and tumor suppression . Antibodies targeting ADAMTS15, such as MAB5149 (R&D Systems), are widely used in research to study its expression, localization, and functional roles .
ADAMTS15 exhibits context-dependent roles in cancer biology:
Tumor Suppression: Downregulated in colon cancer and inversely correlated with metastasis .
Prognostic Marker: High expression in breast cancer associates with poor survival outcomes .
Therapeutic Target: Potential utility in antibody-drug conjugates (ADCs) for targeted cancer therapy, as demonstrated by analogous anti-Tn antibody-MMAF conjugates .
| Sample Type | Sensitivity (95% CI) | Specificity (95% CI) | Reference |
|---|---|---|---|
| Serum | 0.45 (0.29–0.63) | 0.93 (0.86–0.97) | |
| Plasma | 0.38 (0.22–0.56) | 0.89 (0.81–0.94) |
Internalization Efficiency: Anti-Tn antibodies like Chi-Tn mAb demonstrate rapid internalization (~30 minutes), enabling targeted drug delivery .
Cytotoxicity: Conjugation with auristatin F (MMAF) yields IC₅₀ values as low as 7 × 10⁻¹¹ M in Jurkat cells .